Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/30/25 16:42 | 9/26/25 | CRNX | Health | Drug | Pharmaceutical Preparations | Struthers Richard Scott | CA | DO | P,CEO | 3 | S | -1,349 | 43.04 | 0 | -31 | 1,298 | I | |||||||||||||||
9/30/25 16:41 | 9/26/25 | CRNX | Health | Drug | Pharmaceutical Preparations | Fust Matthew K | CA | D | 1 | S.d | -716 | 44.75 | 0 | -16 | 23 | D | ||||||||||||||||
9/4/25 16:30 | 9/2/25 | CRNX | Health | Drug | Pharmaceutical Preparations | Pizzuti Dana | CA | O | Chief Me | 9 | S.d | -4,190 | 40.98 | 0 | -102 | 96 | D | |||||||||||||||
6/16/25 16:48 | 6/12/25 | CRNX | Health | Drug | Pharmaceutical Preparations | Betz Stephen F. | CA | O | Chief Sc | 10 | S.d | -4,411 | 35.21 | 0 | -125 | 109 | D | |||||||||||||||
3/21/25 18:33 | 3/19/25 | CRNX | Health | Drug | Pharmaceutical Preparations | Knight Jeff E. | CA | O | COO | 4 | S.d | -1,801 | 50.55 | 0 | -36 | 87 | D | |||||||||||||||
9/30/24 17:01 | 9/26/24 | CRNX | Health | Drug | Pharmaceutical Preparations | Wilson Marc | CA | O | CFO | 4 | S.d | -5,081 | 50.21 | 0 | -101 | 111 | D | |||||||||||||||
7/9/24 18:04 | 7/5/24 | CRNX | Health | Drug | Pharmaceutical Preparations | Hassard James | CA | O | Chief Co | 2 | S.d | -1,331 | 44.37 | 0 | -30 | 29 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |